4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0001678152-26-000003
Chief Financial Officer bought 700 shares at $16.00 ($11,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keyes Jason A Chief Financial Officer | 2026-08-10 | Purchase | +700 | $16.00 | $11,200 | 700 | D |
| Derivatives | |||||||
| Keyes Jason A Chief Financial Officer | 2026-08-06 | Grant or award · Employee Stock Option (Right to Buy) | +56,746 | 56,746 | D | ||
| Open-market purchases · 700 sh · avg $16.00 · $11,200 | |||||||
Loading xslF345X06/form4-08102026_100815.xml…